Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis | SpringerLink
Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis | Future Medicinal Chemistry
S1P Receptor Modulation in Multiple Sclerosis
Dritter S1P-Modulator bei Multipler Sklerose
Sphingosine-1-phosphate receptor modulator - Wikipedia
Sphingosine‐1‐phosphate receptor modulators in stroke treatment - Zhang - 2022 - Journal of Neurochemistry - Wiley Online Library
Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects | SpringerLink
S1P receptor modulators and the cardiovascular autonomic nervous system in multiple sclerosis: a narrative review - Victor Constantinescu, Rocco Haase, Katja Akgün, Tjalf Ziemssen, 2022
Exploring the Convergence of Advances in S1P Receptor Modulation With…
Mechanism of action of sphingosine receptor modulators. Ozanimod is an... | Download Scientific Diagram
The sphingosine-1-phosphate receptor: A novel therapeutic target for multiple sclerosis and other autoimmune diseases. - Abstract - Europe PMC
S1P受容体 | S1P Receptor
Modulators of Sphingosine-1-phosphate Pathway Biology: Recent Advances of Sphingosine-1-phosphate Receptor 1 (S1P1) Agonists and Future Perspectives | Journal of Medicinal Chemistry
The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: Recent findings and new perspectives - ScienceDirect
Frontiers | Sphingosine-1 Phosphate: A New Modulator of Immune Plasticity in the Tumor Microenvironment
Was die Daten abseits der MS hergeben
Second generation S1P pathway modulators: Research strategies and clinical developments - ScienceDirect
Mechanism of action of s1p receptor modulators in multiple sclerosis: The double requirement - ScienceDirect
Cells | Free Full-Text | Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives
Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions - The Lancet
Cells | Free Full-Text | Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives
Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects | SpringerLink
Review article: the sphingosine 1 phosphate/sphingosine 1 phosphate receptor axis ‐ a unique therapeutic target in inflammatory bowel disease - Wang - 2022 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Sphingosine 1-phosphate (S1P) | Neurology
Mechanism of action of s1p receptor modulators in multiple sclerosis: The double requirement - ScienceDirect
Frontiers | Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases
Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions - The Lancet
